Biomarkers of genetic susceptibility to cancer: Applications to epidemiological studies

Future Oncology

Volumn 1, Issue 1, 2005, Pages 51-56

  Taioli, Emanuela ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Genotype; Methodology; Molecular epidemiology

Indexed keywords

TUMOR MARKER;

ANIMAL; ENVIRONMENTAL EXPOSURE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HUMAN; NEOPLASM; REVIEW;

ANIMALS; ENVIRONMENTAL EXPOSURE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 85047688680     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.1517/14796694.1.1.51     Document Type: Review

References (17)

1. Vineis P, Malats N, Lang M et al.: Metabolic polymorphisms and susceptibility to cancer. IARC Sci. Publ. Lyon, France. 148 (1999).
2. Goldgar DE: Population aspects of cancer genetics. Biochimie 84, 19-25 (2002).
3. Ponder BA: Cancer genetics: Nature 411(6835), 336-341 (2001).
4. Taioli E, Crofts F, Trachman J, Demopoulos R, Garte SJ: A specific African-American polymorphism is associated with adenocarcinoma of the lung. Cancer Res. 55, 472-473 (1995).
5. Garte S, Gaspari L, Taioli E: Metabolic gene polymorphism frequencies in control population. Cancer Epidem. Biom. Prev. 10, 1239-1248 (2001).
6. Wacholder S, Rothman N, Caporaso N: Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidem. Biom. Prev. 11(6), 513-520 (2002).
7. Williams JA: Singel nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Carcinogenesis 22, 209-214 (2001).
8. Khoury MJ, Flanders WD, Beaty TH: Penetrance in the presence of genetic susceptibility to environmental factors. Am. J. Med. Genet. 29(2), 397-403 (1988).
9. Taioli E, Zocchetti C, Garte SJ: Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Env. Health Persp. 106, 67-70 (1998).
10. Brennan P: Gene-environment interaction and etiology of cancer: what does it mean and how can we measure it? Carcinogenesis 23, 381-387 (2002).
11. Deitz AC, Rothman N, Rebbeck TR et al.: Impact of misclassification in genotype- exposure interaction studies: example of Nacetyltransferase 2 (NAT2), smoking, and bladder cancer. Cancer Epidemiol. Biomarkers Prev. 13(9), 1543-1546 (2004).
12. Taioli E, Bonassi S: Methodological issues in pooled analysis of biomarker studies. Mutat. Res. 512, 85 (2002).
13. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C: Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int. J. Epidemiol. 28(1), 1-9 (1999).
14. Taioli E: International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens. Cancer Epidem. Biom. Prev. 8, 727-728 (1999).
15. De Roos AJ, Smith MT, Chanock S, Rothman N: Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies. IARC Sci. Publ. (157), 105-125 (2004).
16. Vineis P, Christiani DC. Genetic testing for sale. Epidemiology 15(1), 3-5 (2004)
17. Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic. Lancet 357(9257), 709-712 (2001).